Objective To explore the high-risk HPV infection status in cervical cancer and the correlation with expression levels of interleukin-6(IL-6), IL-11 and interferon-γ (IFN-γ). Methods The clinical data of 182 patients with cervical cancer who were admitted to the Affiliated Traditional Chinese Medicine Hospital of Guangzhou Medical University and the First Affiliated Hospital of Guangzhou University of Chinese Medicine from January 2021 to December 2024 and received serum IL-6, IL-11 and IFN-γ detection after admission were retrospectively analyzed. All patients underwent relevant examinations to analyze HPV infection status. According to whether HPV infection occurred, they were divided into positive group (n=141) and negative group (n=41). The patients in the positive group were classified into high-risk group (n=94) and low-risk group (n=47) according to whether they had high-risk HPV infection. The differences in levels of serum IL-6, IL-11 and IFN-γ at admission in the groups were compared. Receiver operating characteristic (ROC) curve was applied to analyze the predictive value of serum IL-6, IL-11 and IFN-γ levels at admission on HPV infection and high-risk HPV in patients with cervical cancer. Results Among the 182 patients with cervical cancer from January 2021 to December 2024, there were 141 cases of HPV infection, accounting for 77.47% of the total number of cervical cancer patients, and 94 cases of high-risk HPV infection, accounting for 66.67% of patients with HPV infection. The levels of serum IL-6 and IL-11 in positive group were higher than those in negative group while the level of IFN-γ was lower than that in negative group (all P<0.05). ROC curve showed that the AUCs of serum IL-6, IL-11 and IFN-γ levels in the diagnosis of HPV infection in patients with cervical cancer were 0.813, 0.797 and 0.686 respectively (P<0.05), and the AUC for combined diagnosis of 3 indicators was 0.854(P<0.05). Serum IL-6 and IL-11 level in high-risk group were higher while the IFN-γ level was lower than that in low-risk group (all P<0.05). ROC curve suggested that the AUCs of serum IL-6, IL-11 and IFN-γ in diagnosing high-risk HPV infection in patients with cervical cancer were 0.810, 0.894 and 0.727 respectively (P<0.05), and the AUC for combined diagnosis of 3 indicators was 0.958 (P<0.05). Conclusion Cervical cancer has a high HPV infection rate, with high-risk HPV being the main cause. Combined serum IL-6, IL-11 and IFN-γ indicators have high diagnostic value for cervical cancer with HPV infection and high-risk HPV infection.
Key words
cervical cancer /
human papilloma virus /
interleukin-6 /
interleukin-11 /
IFN-γ
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 蔡会龙, 原伟光. 全球及我国宫颈癌流行现状及防治策略[J]. 临床肿瘤学杂志, 2023, 28(1): 90-93.
[2] 卫飞雪, 冯瑞梅, 高雪, 等.1990-2019年全球宫颈癌疾病负担分析[J]. 中华肿瘤防治杂志, 2024, 31(4): 210-215.
[3] 木朝宇, 张晓梅, 范德胜, 等. 高危型HPV感染亚型分布及其与宫颈病变和宫颈癌的关系[J]. 蚌埠医学院学报, 2023, 48(1): 130-134.
[4] 陈远钦, 黄秋梅, 洪美玲, 等. 高危型HPV病毒载量检测在子宫颈癌筛查和分流中的应用价值基于福建省泉州市子宫颈癌筛查的真实世界回顾性研究[J]. 中华妇产科杂志, 2025, 60(3): 193-201.
[5] 张秀智, 郑小莉, 宋春环, 等. 宫颈癌组织miR-205和CHN1表达与高危型HPV感染及预后的关系研究[J]. 现代生物医学进展, 2024, 24(21): 4110-4115.
[6] ZHANG Z, WANG J, TENG M, et al.The role of serum interleukins in Cancer: a multi-center mendelian randomiza-tion study[J]. Int Immunopharmacol, 2024, 137: 112520.
[7] ZENG L, SUN X.Correlation of INHBA overexpression with pathological features, antitumor immune response and clinical prognosis in cervical cancer[J]. Medicina, 2023, 59(3): 495.
[8] 中华人民共和国国家卫生健康委员会. 宫颈癌诊疗规范 (2018年版)[J]. 肿瘤综合治疗电子杂志, 2020, 6(3): 33-43.
[9] 周小燕, 苗格, 刘艺璇, 等. 延安市宫颈癌发病的生物危险因素的病例对照研究[J]. 现代肿瘤医学, 2023, 31(23): 4383-4387.
[10] 吉宏, 任锦霞, 陈俊瑶, 等.672例宫颈癌前病变及浸润性癌患者HPV感染状况分析[J]. 中国预防医学杂志, 2021, 22(11): 844-848.
[11] 王晓雨, 张瑞敏. 宫颈癌患者HPV感染因素分析及基因型分布[J]. 中国计划生育学杂志, 2024, 32(5): 1162-1166.
[12] VITKAUSKAITE A, URBONIENE D, CELIESIUTE J, et al.Expression of inflammation depending on the stage of cervical cancer[J]. Medicina (Kaunas), 2024, 60(3): 349.
[13] SUN R, CHEN C, DENG X, et al.IL-11 mediates the radioresistance of cervical cancer cells via the PI3K/Akt signaling pathway[J]. J Cancer, 2021, 12(15): 4638-4647.
[14] 祝莉, 郭亚琼, 温媛, 等. Th1/Th2类细胞因子在宫颈癌患者中的表达及与病理组织的相关性研究[J]. 中国妇产科临床杂志, 2022, 23(5): 505-506.
[15] 陈秀英, 陈娜, 李晓丹, 等. 血清Th1/Th2细胞因子联合肿瘤标志物诊断 HR-HPV阳性宫颈癌的价值分析[J]. 检验医学与临床, 2025, 22(9): 1226-1230+1235.
[16] 张颂婕, 叶明珠, 曲长萍, 等. 阴道微生态与宫颈HPV感染患者炎性因子和T细胞亚群的相关性分析[J]. 中国微生态学杂志, 2023, 35(12): 1449-1453.
[17] 赵娟, 惠雪莲, 祝小妮, 等. FKBP14蛋白通过调控IL-6/STAT3通路影响宫颈癌细胞增殖和凋亡的机制研究[J]. 河北医药, 2022, 44(11): 1620-1624.
[18] THUYA WL, CAO Y, HO PC, et al.Insights into IL-6/JAK/STAT3 signaling in the tumor microenvironment: Implications for cancer therapy[J]. Cytokine Growth Factor Rev, 2025, 85: 26-42.